Exercise Intervention for Chemotherapy Induced Peripheral Neuropathy

Phase-Based Progress Estimates
1
Effectiveness
2
Safety
Chemotherapy Induced Peripheral Neuropathy+2 MoreExercise Intervention - Other
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

This trial will compare exercise to the usual approach for treating CIPN to see if it is more effective.

Eligible Conditions
  • Chemotherapy Induced Peripheral Neuropathy
  • Blood Cancer
  • Cancer

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

1 Primary · 0 Secondary · Reporting Duration: Week 6 post randomization

Week 6 post randomization
Chemotherapy-induced peripheral neuropathy (CIPN) symptom severity

Trial Safety

Safety Progress

2 of 3
This is further along than 68% of similar trials

Trial Design

2 Treatment Groups

Arm 2 (usual care)
1 of 2
Arm 1 (EXCAP exercise)
1 of 2

Active Control

Experimental Treatment

120 Total Participants · 2 Treatment Groups

Primary Treatment: Exercise Intervention · No Placebo Group · Phase 2

Arm 1 (EXCAP exercise)
Other
Experimental Group · 1 Intervention: Exercise Intervention · Intervention Types: Other
Arm 2 (usual care)NoIntervention Group · 1 Intervention: Arm 2 (usual care) · Intervention Types:

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: week 6 post randomization

Who is running the clinical trial?

University of Rochester NCORP Research BaseLead Sponsor
11 Previous Clinical Trials
7,963 Total Patients Enrolled
National Cancer Institute (NCI)NIH
13,070 Previous Clinical Trials
41,128,994 Total Patients Enrolled
Ian R KlecknerPrincipal InvestigatorUniversity of Rochester NCORP Research Base

Eligibility Criteria

Age 18+ · All Participants · 8 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You have an Eastern Cooperative Oncology Group (ECOG) performance status of 0-1.
You are at least 18 years of age.